Your browser doesn't support javascript.
loading
Diagnosis and management of bone fragility in diabetes: an emerging challenge.
Ferrari, S L; Abrahamsen, B; Napoli, N; Akesson, K; Chandran, M; Eastell, R; El-Hajj Fuleihan, G; Josse, R; Kendler, D L; Kraenzlin, M; Suzuki, A; Pierroz, D D; Schwartz, A V; Leslie, W D.
Afiliación
  • Ferrari SL; Division of Bone Diseases, Department of Internal Medicine Specialties, Geneva University Hospital & Faculty of Medicine, 1205, Geneva, Switzerland. serge.ferrari@unige.ch.
  • Abrahamsen B; Department of Medicine, Holbaek Hospital, Holbaek, Denmark.
  • Napoli N; OPEN, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Akesson K; Unit of Endocrinology and Diabetes, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Chandran M; Division of Bone and Mineral Diseases, Washington University in St Louis, St Louis, MO, USA.
  • Eastell R; Department of Clinical Sciences, Clinical and Molecular Osteoporosis Unit, Lund University, Malmö, Sweden.
  • El-Hajj Fuleihan G; Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
  • Josse R; Academic Unit of Bone Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK.
  • Kendler DL; Department of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Riad El Solh, Beirut, Lebanon.
  • Kraenzlin M; Department of Medicine and Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada.
  • Suzuki A; Division of Endocrinology and Metabolism, St. Michael's Hospital, Toronto, ON, Canada.
  • Pierroz DD; Department of Medicine, Division of Endocrinology, University of British Columbia, Vancouver, BC, Canada.
  • Schwartz AV; Endonet, Endocrine Clinic and Laboratory, Basel, Switzerland.
  • Leslie WD; Division of Endocrinology and Metabolism, Fujita Health University, Toyoake, Aichi, Japan.
Osteoporos Int ; 29(12): 2585-2596, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30066131
ABSTRACT
Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the identification and management of fracture risk in these patients remains challenging. This review explores the clinical characteristics of bone fragility in adults with diabetes and highlights recent studies that have evaluated bone mineral density (BMD), bone microstructure and material properties, biochemical markers, and fracture prediction algorithms (i.e., FRAX) in these patients. It further reviews the impact of diabetes drugs on bone as well as the efficacy of osteoporosis treatments in this population. We finally propose an algorithm for the identification and management of diabetic patients at increased fracture risk.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Fracturas Osteoporóticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Fracturas Osteoporóticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article